S
21.51
-0.41 (-1.87%)
| 前收盘价格 | 21.92 |
| 收盘价格 | 21.85 |
| 成交量 | 1,492,436 |
| 平均成交量 (3个月) | 1,459,886 |
| 市值 | 10,631,058,432 |
| 市盈率 (P/E TTM) | 19.38 |
| 预期市盈率 (P/E Forward) | 15.17 |
| 价格/销量 (P/S) | 0.970 |
| 股市价格/股市净资产 (P/B) | 1.20 |
| 52周波幅 | |
| 利润日期 | 19 Feb 2026 |
| 股息率 (DY TTM) | 4.93% |
| 营业毛利率 | 5.85% |
| 营业利益率 (TTM) | 9.33% |
| 稀释每股收益 (EPS TTM) | 1.14 |
| 季度收入增长率 (YOY) | 8.40% |
| 季度盈利增长率 (YOY) | 17.00% |
| 总债务/股东权益 (D/E MRQ) | 57.56% |
| 流动比率 (MRQ) | 1.03 |
| 营业现金流 (OCF TTM) | 1.24 B |
| 杠杆自由现金流 (LFCF TTM) | 680.49 M |
| 资产报酬率 (ROA TTM) | 4.01% |
| 股东权益报酬率 (ROE TTM) | 7.16% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (AU) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | SONIC HLTH FPO [SHL] | - | - |
AIStockmoo 评分
-0.5
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | -0.50 |
|
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Value |
| 内部持股比例 | 5.37% |
| 机构持股比例 | 40.29% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合